Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer
Patients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-03, phase 3 clinical trial tested the effects of giving ICIs again, as part of a standard second-line ...
Jun 5, 2023
0
3